FDA
Doxazosin Mesylate
The FDA lists this product in 60 strengths and forms.
Composition
- Active ingredients
- DOXAZOSIN MESYLATE EQ 2MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DOXAZOSIN MESYLATE EQ 8MG BASE · TabletANDA202824-004 · Prescription
- DOXAZOSIN MESYLATE EQ 2MG BASE · TabletANDA202824-002 · Prescription
- DOXAZOSIN MESYLATE EQ 4MG BASE · TabletANDA202824-003 · Prescription
- DOXAZOSIN MESYLATE EQ 1MG BASE · TabletANDA202824-001 · Prescription
- DOXAZOSIN MESYLATE EQ 4MG BASE · TabletANDA075646-003 · Discontinued
- DOXAZOSIN MESYLATE EQ 1MG BASE · TabletANDA075646-001 · Discontinued
- DOXAZOSIN MESYLATE EQ 8MG BASE · TabletANDA075646-004 · Discontinued
- DOXAZOSIN MESYLATE EQ 2MG BASE · TabletANDA075646-002 · Discontinued
- DOXAZOSIN MESYLATE EQ 4MG BASE · TabletANDA212727-003 · Prescription
- DOXAZOSIN MESYLATE EQ 1MG BASE · TabletANDA212727-001 · Prescription
- DOXAZOSIN MESYLATE EQ 8MG BASE · TabletANDA212727-004 · Prescription
- DOXAZOSIN MESYLATE EQ 2MG BASE · Tablet
At a glance
- Brand name
- Doxazosin Mesylate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Watson Labs Inc
- Status
- Discontinued
- FDA approval
- 18 Oct 2000
- Application
- ANDA075426-002